Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle R Lofwall

Showing results (41-50 of 126) with videos related to

Pageof 13
Sort By:
Psychopharmacology|May 14, 2021
Evaluation of tradipitant, a selective NK1 antagonist, on response to oxycodone in humansMarion A Coe, Michelle R Lofwall, Victoria Vessels, et al.
Journal of Clinical Pharmacology|June 3, 2015
Quinine as a potential tracer for medication adherence: A pharmacokinetic and pharmacodynamic assessment of quinine alone and in combination with oxycodone in humansShanna Babalonis, Aidan J Hampson, Michelle R Lofwall, et al.
Drug and Alcohol Dependence|May 29, 2016
Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humansMichelle R Lofwall, Shanna Babalonis, Paul A Nuzzo, et al.
Journal of Substance Abuse Treatment|April 29, 2005
Characteristics of older opioid maintenance patientsMichelle R Lofwall, Robert K Brooner, George E Bigelow, et al.
Drug and Alcohol Dependence|October 27, 2012
Abuse liability and reinforcing efficacy of oral tramadol in humansShanna Babalonis, Michelle R Lofwall, Paul A Nuzzo, et al.
Psychopharmacology|July 29, 2010
Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potenciesWilliam W Stoops, Kevin W Hatton, Michelle R Lofwall, et al.
Drug and Alcohol Dependence|March 25, 2018
Perceptions and practices addressing diversion among US buprenorphine prescribersLewei Allison Lin, Michelle R Lofwall, Sharon L Walsh, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|May 24, 2022
Changes in transmucosal buprenorphine utilization for opioid use disorder treatment during the COVID-19 pandemic in KentuckyFeitong Lei, Michelle R Lofwall, Patricia R Freeman, et al.
Preventive Medicine|July 12, 2020
Longitudinal trends in nonmedical prescription opioid use in a cohort of rural Appalachian people who use drugsJennifer R Havens, Hannah K Knudsen, April M Young, et al.
Journal of Addiction Medicine|September 16, 2017
Physicians' Decision-making When Implementing Buprenorphine With New Patients: Conjoint Analyses of Data From a Cohort of Current PrescribersHannah K Knudsen, Michelle R Lofwall, Sharon L Walsh, et al.
Pageof 13

Showing results (41-50 of 126) with videos related to

Sort By:
Pageof 13
Psychopharmacology|May 14, 2021
Evaluation of tradipitant, a selective NK1 antagonist, on response to oxycodone in humansMarion A Coe, Michelle R Lofwall, Victoria Vessels, et al.
Journal of Clinical Pharmacology|June 3, 2015
Quinine as a potential tracer for medication adherence: A pharmacokinetic and pharmacodynamic assessment of quinine alone and in combination with oxycodone in humansShanna Babalonis, Aidan J Hampson, Michelle R Lofwall, et al.
Drug and Alcohol Dependence|May 29, 2016
Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humansMichelle R Lofwall, Shanna Babalonis, Paul A Nuzzo, et al.
Journal of Substance Abuse Treatment|April 29, 2005
Characteristics of older opioid maintenance patientsMichelle R Lofwall, Robert K Brooner, George E Bigelow, et al.
Drug and Alcohol Dependence|October 27, 2012
Abuse liability and reinforcing efficacy of oral tramadol in humansShanna Babalonis, Michelle R Lofwall, Paul A Nuzzo, et al.
Psychopharmacology|July 29, 2010
Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potenciesWilliam W Stoops, Kevin W Hatton, Michelle R Lofwall, et al.
Drug and Alcohol Dependence|March 25, 2018
Perceptions and practices addressing diversion among US buprenorphine prescribersLewei Allison Lin, Michelle R Lofwall, Sharon L Walsh, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|May 24, 2022
Changes in transmucosal buprenorphine utilization for opioid use disorder treatment during the COVID-19 pandemic in KentuckyFeitong Lei, Michelle R Lofwall, Patricia R Freeman, et al.
Preventive Medicine|July 12, 2020
Longitudinal trends in nonmedical prescription opioid use in a cohort of rural Appalachian people who use drugsJennifer R Havens, Hannah K Knudsen, April M Young, et al.
Journal of Addiction Medicine|September 16, 2017
Physicians' Decision-making When Implementing Buprenorphine With New Patients: Conjoint Analyses of Data From a Cohort of Current PrescribersHannah K Knudsen, Michelle R Lofwall, Sharon L Walsh, et al.
Pageof 13